Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.44 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.41 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | BACE1 | P56817 | 1/20 | 0.40 |
| ▸ | AURKA | O14965 | 1/20 | 0.40 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.40 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20164147 | 0.85 | PTGDR2 (0.45) | KMT2AMEN1RXFP1PTGDR2CYP1A2 | |
| SCHEMBL12551788 | 0.80 | MGLL (0.50) | KMT2AMEN1ALDH1A1SMN1; SMN2NPC1 | |
| SCHEMBL25217035 | 0.78 | ESR2 (0.46) | KMT2AMEN1PTGDR2MAPK1ALDH1A1 | |
| SCHEMBL8067754 | 0.78 | CA2 (0.54) | ALDH1A1BACE1ESR2HPGDHSD17B10 | |
| SCHEMBL30421069 | 0.78 | ESR2 (0.46) | KMT2AMEN1PTGDR2MAPK1ALDH1A1 | |
| SCHEMBL3655307 | 0.77 | PTGDR2 (0.41) | PTGDR2MAPK1ALDH1A1BACE1ESR2 | |
| SCHEMBL28972658 | 0.77 | ESR2 (0.40) | KMT2AMEN1CYP1A2BACE1ESR2 | |
| SCHEMBL28545275 | 0.77 | METAP2 (0.37) | KMT2AMEN1RXFP1PTGDR2CYP1A2 | |
| SCHEMBL29664280 | 0.76 | SLC6A4 (0.47) | KMT2AMEN1CYP1A2ALDH1A1SMN1; SMN2 | |
| SCHEMBL1742339 | 0.76 | SLC6A4 (0.47) | KMT2AMEN1CYP1A2ALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116332914-B | Compound for organic electric element, organic electric element using the same, and electronic device using the same | 德山新勒克斯有限公司 | 2025-04-15 | — | — | CN | disclosed |
| CN-111836872-B | Compound for organic electric element, organic electric element using the same, and electronic device using the same | 德山新勒克斯有限公司 | 2023-10-24 | — | — | CN | disclosed |
| CN-116507623-A | Heterocyclic compound, organic light-emitting element comprising same, method for producing same, and composition for organic layer | LT素材株式会社 | 2023-07-28 | — | — | CN | disclosed |
| CN-116332914-A | Compound for organic electric element, organic electric element using the same, and electronic device using the same | 德山新勒克斯有限公司 | 2023-06-27 | — | — | CN | disclosed |
| CN-116332916-A | Compound for organic electric element, organic electric element using the same, and electronic device using the same | 德山新勒克斯有限公司 | 2023-06-27 | — | — | CN | disclosed |
| US-11538996-B2 | Materials for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2022-12-27 | — | — | US | disclosed |
| EP-3679024-B1 | MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2022-11-02 | — | — | EP | disclosed |
| CN-111836872-A | Compound for organic electric element, organic electric element using the same, and electronic device thereof | 德山新勒克斯有限公司 | 2020-10-27 | — | — | CN | disclosed |
| US-20200283386-A1 | MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2020-09-10 | — | — | US | disclosed |
| EP-3419960-B1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2020-07-01 | — | — | EP | disclosed |
| US-9716232-B2 | Material for organic light-emitting device, and organic light-emitting device using same | LG CHEM, LTD. (KR) | 2017-07-25 | — | — | US | disclosed |
| EP-2755253-B1 | MATERIAL FOR ORGANIC LIGHT-EMITTING DEVICE, AND ORGANIC LIGHT-EMITTING DEVICE USING SAME | LG CHEMICAL LTD (KR) | 2017-06-28 | — | — | EP | disclosed |
| CN-103797604-B | Material for organic light emitting device and organic light emitting device using the same | 株式会社LG化学 | 2017-02-15 | — | — | CN | disclosed |
| US-9553270-B2 | Material for organic light-emitting device, and organic light-emitting device using same | LG CHEM, LTD. (KR) | 2017-01-24 | — | — | US | disclosed |
| CN-103797605-B | Material for organic light emitting device and organic light emitting device using the same | 株式会社LG化学 | 2016-12-21 | — | — | CN | disclosed |
| US-20140231774-A1 | MATERIAL FOR ORGANIC LIGHT-EMITTING DEVICE, AND ORGANIC LIGHT-EMITTING DEVICE USING SAME | LG CHEM, LTD. (KR) | 2014-08-21 | — | — | US | disclosed |
| US-20140183517-A1 | MATERIAL FOR ORGANIC LIGHT-EMITTING DEVICE, AND ORGANIC LIGHT-EMITTING DEVICE USING SAME | LG CHEM, LTD. (KR) | 2014-07-03 | — | — | US | disclosed |
| EP-2198867-A1 | Pyrimidine-based compounds useful as GSK-3 inhibitors | Vertex Pharmaceuticals, Inc. (US) | 2010-06-23 | — | — | EP | disclosed |
| EP-1474147-B1 | PYRIMIDINE-BASED COMPOUNDS USEFUL AS GSK-3 INHIBITORS | VERTEX PHARMA (US) | 2010-05-05 | — | — | EP | disclosed |
| US-20030199526-A1 | Pyrimidine-based compounds useful as GSK-3 inhibitors | VERTEX PHARMACEUTICALS, INCORPORATED | 2003-10-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030199526-A1 | Pyrimidine-based compounds useful as GSK-3 inhibitors | GSK3B, GSK3A, GSKIP | KMT2A 2096/4885MEN1 3790/4885RXFP1 4566/4885 |
| US-11538996-B2 | Materials for organic electroluminescent devices | RIF1, INTS9, LEF1 | KMT2A 3719/4885MEN1 138/4885RXFP1 3415/4885 |
| US-20200283386-A1 | MATERIALS FOR ELECTRONIC DEVICES | EFNA1, GPX1, SOD1 | KMT2A 2546/4885MEN1 408/4885RXFP1 4820/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.